GRIN2D provides instructions for part of an NMDA receptor, a protein that helps brain cells send signals, learn, and develop normally. In medicine, this gene is important because it helps regulate how nerve cells respond to glutamate, a key brain messenger. If the GRIN2D gene does not work properly, brain signaling can become too high or too low, which may lead to seizures, developmental delay, movement differences, and learning problems. Most people hear about GRIN2D through genetic testing for early-onset epilepsy or neurodevelopmental conditions.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they occur, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
GRIN2DGene function
What if the gene works
The GRIN2D gene helps build part of an NMDA receptor, a brain cell protein that responds to glutamate. This supports cell-to-cell signaling involved in brain development and learning.
Risk
What if the gene does not work
Variants in the GRIN2D gene can affect brain signaling and are linked to a neurodevelopmental condition that may include developmental delay, low muscle tone, movement differences, and epilepsy; effects range from mild to more severe.
Treatment
What does that mean for your treatment
No GRIN2D-specific treatment or drug selection approach is currently established in clinical guidelines for pathogenic or loss-of-function variants in the GRIN2D gene. The GRIN2D gene is being studied as a possible target for medicines that adjust NMDA receptor signaling, but this remains early research and has not defined standard care.
Conditions associated with GRIN2D
Gene function
What if the gene works
In the brain, the GRIN2D gene helps nerve cells pass messages with the right timing. It provides instructions for one part of an NMDA receptor, a protein channel that responds to glutamate. This is a key part of what the GRIN2D gene does in nerve cells, helping brain circuits adapt during development and learning.
The GRIN2D gene provides instructions for the GluN2D piece of an NMDA receptor on nerve cells. This piece helps the receptor detect the messenger glutamate and join normal brain signaling.
When the receptor is switched on, it opens a channel that lets calcium and sodium move into the cell. This helps turn an outside chemical message into an internal signal that nerve cells can use.
NMDA receptors that include the GRIN2D protein help control how strongly synapses respond to activity over time. This supports synaptic plasticity (the brain's ability to adjust connections), which is important for learning and memory.
This gene is active in the developing brain and helps young nerve networks organize their signaling. It also contributes to the timing and pattern of communication in some mature brain circuits.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GRIN2D gene can change the shape or behavior of the NMDA receptor subunit it encodes, altering how the channel opens, closes, or reaches the cell surface. In the effects of GRIN2D gene variants, DNA changes can range from milder variants to more severe variants: some reduce receptor activity, while others make it overly active. This functional range can influence whether GRIN2D-related neurodevelopmental symptoms appear earlier or are more pronounced.
How variants are linked to conditions
Pathogenic variants in the GRIN2D gene are linked to a rare GRIN2D gene variant and epilepsy condition called developmental and epileptic encephalopathy 46. This condition can include seizures starting in infancy or early childhood, along with developmental delay, low muscle tone, movement differences, and intellectual disability. Some people with a GRIN2D-related condition have marked developmental challenges even when seizures are not the main feature.
A variant is not necessarily a diagnosis
Across humans, genetic variants are common and are a normal part of biology. Most do not have a direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant connected with a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some instances, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the GRIN2D gene. For many living with a GRIN2D change, risk is shaped mainly by the specific variant itself rather than lifestyle or everyday exposures, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of GRIN2D variants
Variants in the GRIN2D gene are inherited in an autosomal dominant pattern, which means one changed copy can be enough to cause a GRIN2D-related condition. If a parent carries a disease-causing variant in the GRIN2D gene, each child has a 50% chance of inheriting it. Most reported cases so far have happened because of a new (de novo) variant, meaning the change was not inherited from either parent. In practical terms, how variants of the GRIN2D gene are inherited can involve either a parent-to-child pattern or a new change arising for the first time in the child.
What does my GRIN2D result mean for my family?
For GRIN2D, a disease-causing result is usually linked to a dominant pattern, which means close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, though, the change happened new in the affected child and was not inherited from either parent. That means family implications can differ, and testing results in parents often help clarify what it may mean for siblings or future children.
Genetic information
Genetic testing
How you find out about variants
Variants in the GRIN2D gene are usually found through genetic testing for GRIN2D variants, using a blood sample, saliva, or cheek swab. A lab reads the gene’s DNA code to look for changes and reports whether a variant is known to help explain a person’s symptoms or development.
When should I consider getting a genetic test?
Genetic testing for the GRIN2D gene may be worth considering when a child has unexplained early-life seizures, developmental delay, low muscle tone, or unusual movement problems. It can also help when there is a family history of a related brain development condition or a known GRIN2D variant.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment works well for one person but less well for another, or why some people are more likely to notice side effects. Small differences in how the body absorbs, breaks down, or responds to a drug are common and can influence both benefit and sensitivity. Medication response is also shaped by age, other health conditions, and other medicines you take.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can help support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the GRIN2D gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or treatment changes are best discussed with your doctor. GRIN2D has been studied in rare brain and seizure conditions to see whether some brain-acting medicines may help, but this is still specialized research rather than routine care.
History
GRIN2D entered the scientific literature in the early 1990s, during a period when researchers were identifying different members of the NMDA receptor gene family. It was first described through laboratory studies of brain tissue, which helped place it among a group of related genes involved in signaling between nerve cells. Building on this early work, scientists later mapped the GRIN2D gene to chromosome 19 and compared it with other receptor genes to understand how this family evolved. Much later, advances in DNA sequencing linked rare GRIN2D variants to certain neurodevelopmental conditions, bringing the gene into clinical genetics. Over time, descriptions became more precise as research moved from basic gene discovery to clearer medical interpretation.